佳寧娜(00126.HK)完成配發1.886億股認購股份 淨籌8330萬港元
格隆匯6月8日丨佳寧娜(00126.HK)發佈公吿,股份認購已根據股份認購協議的條款及條件於2021年6月8日完成。股份認購完成時,188,563,130股認購股份已由公司按每股0.45港元的認購價正式配發及發行予認購人。
其中94,281,565股認購股份正式配發及發行予馬介璋先生,及其他94,281,565股認購股份正式配發及發行予馬介欽先生。認購股份相當於公司經擴大繳足已發行股本的約12%。股份認購的所得款項淨額約為8330萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.